The brain is a promising area for growth investments. Yet lately, it hasn’t produced a whole lot of exits.
Those are some takeaways from an interview earlier this week with Roger Quy, a neuroscience Ph.D. and general partner at Technology Partners who has carved out a niche investing in what might be called the “brain space.”
It’s a focus area involving companies applying advancements in brain science to everything from mental illness therapies to market research. And while in some ways it’s a classic growth sector – particularly with advances in research promising treatments for diseases previously considered uncurable – it’s also a challenging one, Quy pointed out in Q&A sessions, excerpts of which follow: